Close Close Comment Creative Commons Donate Email Add Email Facebook Instagram Facebook Messenger Mobile Nav Menu Podcast Print RSS Search Secure Twitter WhatsApp YouTube

General Electric’s Comments to our Omniscan Stories -- and Our Response

GE Healthcare criticizes our stories about Omniscan, its MRI drug linked to a crippling disease, and we respond to the criticism.

GE Healthcare has posted several comments criticizing our stories about MRI patients who developed a crippling disease after using the company's MRI drug, Omniscan. We encourage feedback and have responded to company spokesman Jeff DeMarrais. See our comments at "GE’s Own Safety Team Urged Company to Restrict MRI Drug" (comments) and "Judge Opens Door to Case Against General Electric’s Omniscan" (comments).

Tom Detzel

Tom Detzel was a senior editor at ProPublica. Previously, Detzel was an editor at the Oregonian beginning in 1995 and was the newspaperâs investigations editor starting in 2004.

Latest Stories from ProPublica

Current site Current page